Chemistry:ATC code J02
From HandWiki
Template:ATC code J ATC code J02 Antimycotics for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2] Subgroup J02 is part of the anatomical group J Antiinfectives for systemic use.[3]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ02.[4] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
J02A Antimycotics for systemic use
J02AA Antibiotics
- J02AA01 Amphotericin B
- J02AA02 Hachimycin
J02AB Imidazole derivatives
- J02AB01 Miconazole
- J02AB02 Ketoconazole
- QJ02AB90 Clotrimazole
- J02AC01 Fluconazole
- J02AC02 Itraconazole
- J02AC03 Voriconazole
- J02AC04 Posaconazole
- J02AC05 Isavuconazole
- J02AC06 Oteseconazole
J02AX Other antimycotics for systemic use
- J02AX01 Flucytosine
- J02AX04 Caspofungin
- J02AX05 Micafungin
- J02AX06 Anidulafungin
- J02AX07 Ibrexafungerp
- J02AX08 Rezafungin acetate
References
- ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/ATC/index.html. Retrieved 2020-02-01.
- ↑ "ATC-Klassifikation mit definierten Tagesdosen DDD". German Institute for Medical Documentation and Information. https://www.dimdi.de/dynamic/de/arzneimittel/atc-klassifikation/. Retrieved 2020-02-01.
- ↑ "ATC/DDD Index 2020: code J02". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/?code=J02.
- ↑ "ATCvet Index 2020: code QJ02". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/?code=J02.
 |  |
